Literature DB >> 3048944

Oscillatory potentials as a marker for dopaminergic disease.

M F Marmor1, P Hock, G Schechter, A Pfefferbaum, P A Berger, R Maurice.   

Abstract

In an effort to find electrophysiologic correlates of dopaminergic disease in man, we measured oscillatory potentials of the electroretinogram in normal and unmedicated schizophrenic subjects, and in rabbits given D1 agonist or antagonist drugs. We found highly reproducible oscillatory potentials in twelve male schizophrenics that were indistinguishable from those in nine male normal volunteers. We also found little electroretinographic difference among four rabbits given intramuscular injections of SKF 38393 (a D1 agonist) and four control animals injected with saline. However, four animals given SCH 23390 (a D1 antagonist) showed diminution of the b-wave and selective suppression of the second oscillatory potential. This effect was more prominent in oscillatory potentials generated by 5-Hz flicker than by a single flash. These rabbit data suggest that further efforts at finding clinical correlations may be worthwhile, possibly with trial of flicker oscillatory potentials, and they support the concept that different oscillatory potentials have different generators.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048944     DOI: 10.1007/BF00154406

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  6 in total

1.  Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina.

Authors:  R J Jensen; N W Daw
Journal:  Neuroscience       Date:  1986-03       Impact factor: 3.590

Review 2.  Neurotransmitter systems in the retina.

Authors:  B Ehinger
Journal:  Retina       Date:  1982       Impact factor: 4.256

3.  Origin of the oscillatory potentials in the primate retina.

Authors:  H Heynen; L Wachtmeister; D van Norren
Journal:  Vision Res       Date:  1985       Impact factor: 1.886

4.  Further studies of the chemical sensitivity of the oscillatory potentials of the electroretinogram (ERG). II. Glutamate-aspartate-and dopamine antagonists.

Authors:  L Wachtmeister
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-04

5.  Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.

Authors:  J Hyttel
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

6.  The central effects of a novel dopamine agonist.

Authors:  P E Setler; H M Sarau; C L Zirkle; H L Saunders
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

  6 in total
  10 in total

1.  The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans.

Authors:  P Bartel; M Blom; E Robinson; C van der Meyden; D K Sommers; P Becker
Journal:  Doc Ophthalmol       Date:  1990-11       Impact factor: 2.379

2.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

3.  Electroretinographic effects of haloperidol on the mouse retina.

Authors:  A Mizota; E Adachi-Usami
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 4.  Role of dopamine in distal retina.

Authors:  E Popova
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-04-12       Impact factor: 1.836

5.  The effects of dopamine blockade on the human flash electroretinogram.

Authors:  K Holopigian; L Clewner; W Seiple; M J Kupersmith
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

6.  Distinct electroretinographic oscillatory potential generators as revealed by field distribution.

Authors:  F Tremblay; S R Lam
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 7.  THE USE OF ELECTRORETINOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH SCHIZOPHRENIA.

Authors:  Din Duraković; Ante Silić; Vjekoslav Peitl; Rašeljka Tadić; Kristina Lončarić; Trpimir Glavina; Daniela Šago; Ljiljana Pačić Turk; Dalibor Karlović
Journal:  Acta Clin Croat       Date:  2020-12       Impact factor: 0.932

8.  Effects of dopamine D1 receptor blockade on the ERG b- and d-waves during blockade of ionotropic GABA receptors.

Authors:  Elka Popova; Momchil Kostov; Petia Kupenova
Journal:  Eye Vis (Lond)       Date:  2016-12-07

9.  Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis.

Authors:  Nathalia Torres Jimenez; Justin W Lines; Rachel B Kueppers; Paulo Kofuji; Henry Wei; Amy Rankila; Joseph T Coyle; Robert F Miller; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

10.  Schizophrenia and the eye.

Authors:  Steven M Silverstein; Richard Rosen
Journal:  Schizophr Res Cogn       Date:  2015-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.